Miranda H. Kleijn
Uppsalalaan 12, 3584, CT
Utrecht, UT, Netherlands
Utrecht, UT, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Selection of Patients With Early-Stage Breast Cancer for Extended Endocrine Therapy: A Secondary Analysis of the IDEAL Randomized Clinical Trial.
Journal: JAMA network open
Published: November 27, 2024
Efficacy, safety, and predictive biomarkers of neoadjuvant nab-paclitaxel and pembrolizumab in hormone receptor-positive breast cancer: A randomized pilot trial.
Journal: Nature communications
Published: October 02, 2024
BluePrint molecular subtypes predict response to neoadjuvant pertuzumab in HER2-positive breast cancer.
Journal: Breast cancer research : BCR
Published: November 15, 2022
Factors Affecting Adherence, Intake, and Perceived Palatability of Oral Nutritional Supplements: A Literature Review.
Journal: The journal of nutrition, health & aging
Published: July 17, 2022
Validation of the 70-gene signature test (MammaPrint) to identify patients with breast cancer aged ≥ 70 years with ultralow risk of distant recurrence: A population-based cohort study.
Journal: Journal of geriatric oncology
Published: December 13, 2021
Treatment response and 5-year distant metastasis-free survival outcome in breast cancer patients after the use of MammaPrint and BluePrint to guide preoperative systemic treatment decisions.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 25, 2021
Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature.
Journal: Breast cancer research and treatment
Published: November 19, 2021
Local Oestrogen for Pelvic Floor Disorders: A Systematic Review.
Journal: PloS one
Published: March 24, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026